{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:00:04Z","timestamp":1788184804107,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.clinthera.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T02:02:40Z","timestamp":1449972160000},"page":"110-121","source":"Crossref","is-referenced-by-count":9,"title":["Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs"],"prefix":"10.1016","volume":"38","author":[{"given":"Philip","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Durden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.11.011_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to the position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2015.11.011_bib2","first-page":"S5","article-title":"Standards of medical care in diabetes--2015","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinthera.2015.11.011_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2015.11.011_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1463-1326.2011.01487.x","article-title":"The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus","volume":"14","author":"Asche","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2015.11.011_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1532-5415.2005.53370.x","article-title":"Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus?","volume":"53","author":"Chaudhry","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2015.11.011_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1463-1326.2011.01405.x","article-title":"Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy","volume":"13","author":"Fu","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2015.11.011_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/diacare.27.7.1535","article-title":"The burden of treatment failure in type 2 diabetes","volume":"27","author":"Brown","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1464-5491.2004.01095.x","article-title":"Clinical inertia in the management of type 2 diabetes metabolic risk factors","volume":"21","author":"Grant","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2015.11.011_bib10","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib11","unstructured":"Centers for Disease Control and Prevention. Classification of Diseases, Functioning, and Disability. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). http:\/\/www.cdc.gov\/nchs\/icd\/icd9cm.htm. Accessed October 31, 2014."},{"key":"10.1016\/j.clinthera.2015.11.011_bib12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2337\/dc06-9912","article-title":"Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"29","author":"Nathan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2015.11.011_bib14","unstructured":"United States Department of Labor. Bureau of Labor Statistics. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999\u20132008, Medical Care. Series ID: SUUR0000SAM. http:\/\/data.bls.gov\/cgi-bin\/surveymost?su. Accessed October 31, 2014."},{"key":"10.1016\/j.clinthera.2015.11.011_bib15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/dc11-2048","article-title":"Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes","volume":"35","author":"Zhao","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6823-8-4","article-title":"Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits","volume":"8","author":"Ginde","year":"2008","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.clinthera.2015.11.011_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4158\/EP13159.OR","article-title":"Real-world insulin treatment persistence among patients with type 2 diabetes","volume":"20","author":"Wei","year":"2014","journal-title":"Endocr Pract"},{"issue":"10 Suppl 2","key":"10.1016\/j.clinthera.2015.11.011_bib18","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/MLR.0b013e31806518ac","article-title":"Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases","volume":"45","author":"Curtis","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwj047","article-title":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect","volume":"163","author":"Kurth","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinthera.2015.11.011_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0272989X09341755","article-title":"The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies","volume":"29","author":"Austin","year":"2009","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2015.11.011_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1020371312283","article-title":"Estimation of causal effects using propensity score weighting: an application to data on right heart catheterization","volume":"2","author":"Hirano","year":"2001","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"10.1016\/j.clinthera.2015.11.011_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/dom.12131","article-title":"Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin","volume":"15","author":"Dailey","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2015.11.011_bib23","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00125-013-2856-6","article-title":"Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis","volume":"56","author":"Hirst","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2015.11.011_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3111\/13696998.2011.605818","article-title":"Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID","volume":"14","author":"Baser","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.clinthera.2015.11.011_bib26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s12325-011-0074-5","article-title":"A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens","volume":"28","author":"Xie","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2015.11.011_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/CEOR.S49279","article-title":"Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs","volume":"5","author":"Baser","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.clinthera.2015.11.011_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1185\/03007995.2013.811403","article-title":"Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy","volume":"29","author":"Davis","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2015.11.011_bib29","doi-asserted-by":"crossref","first-page":"e002348","DOI":"10.1136\/bmjopen-2012-002348","article-title":"Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study","volume":"3","author":"Wang","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2015.11.011_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2004-1133","article-title":"Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis","volume":"90","author":"Ferrannini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2015.11.011_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00395-013-0365-x","article-title":"Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus","volume":"108","author":"Moberly","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.clinthera.2015.11.011_bib32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12325-013-0074-8","article-title":"The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy","volume":"30","author":"Thayer","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2015.11.011_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3111\/13696998.2013.862538","article-title":"Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study","volume":"17","author":"Curtis","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.clinthera.2015.11.011_bib34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc09-0653","article-title":"Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?","volume":"32","author":"Lingvay","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.11.011_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1185\/03007990802715199","article-title":"Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine","volume":"25","author":"Fabunmi","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2015.11.011_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diabres.2009.09.023","article-title":"Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis","volume":"87","author":"Lee","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinthera.2015.11.011_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3810\/pgm.2013.05.2656","article-title":"Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial","volume":"125","author":"Grabner","year":"2013","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clinthera.2015.11.011_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/dia.2012.0253","article-title":"Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus","volume":"15","author":"Xie","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.clinthera.2015.11.011_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jgs.13388","article-title":"A real-world study of the effect of timing of insulin initiation on outcomes in older Medicare beneficiaries with type 2 diabetes mellitus","volume":"63","author":"Bhattacharya","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2015.11.011_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2337\/dc13-2097","article-title":"Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012","volume":"37","author":"Turner","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815012400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815012400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T01:36:52Z","timestamp":1656207412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815012400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0149291815012400"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.11.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}